Traphaco Joint Stock Company announced on 21/11 that Tran Tuc Ma has handed over the general director's responsibilities to Dao Thuy Ha. Ma will, however, continue to serve as a member of the company's Board of Directors (BOD).

Tran Tuc Ma stated that despite being in good health, having time left in his term, and the company experiencing good growth, he decided to resign to allow Traphaco to have a leadership team suitable for its new development phase.

Tran Tuc Ma, Traphaco Board of Directors member. *Photo: TRA*

Tran Tuc Ma, born in 1965, served as Traphaco's General Director from 3/2011. He joined the company in 1994, dedicating over 30 years to various roles including Head of Sales, Head of the Supervisory Board, and a member of the Board of Directors. Currently, he owns over 1.7 million TRA shares, representing 4.16% of the company's capital.

Under Ma's leadership, Traphaco consistently generated thousands of billions of VND in revenue annually, with profits exceeding hundreds of billions of VND. For the first nine months, the company reported 1,936 billion VND in revenue and 179 billion VND in net profit, both increasing by 12% compared to the same period last year. This performance indicates the company has completed 75% of its annual plan.

Traphaco's new General Director, Dao Thuy Ha, born in 1975, holds a Master's degree in Pharmacy and a Master's degree in Business Administration. She joined the company in 1996. Prior to this appointment, she served as Deputy General Director for Sales and Marketing, a member of the Board of Directors, and represented 11.55% of the State Capital Investment Corporation (SCIC)'s capital in the company.

Established in 1972, Traphaco specializes in pharmaceutical production and distribution. The company was equitized in 2000 and officially listed its shares in 2008. Currently, the State Capital Investment Corporation (SCIC) is Traphaco's largest shareholder, holding 35.7% of the capital. Foreign shareholders collectively hold over 46% of the shares.

Trong Hieu